Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer: Role in Clinical Management and Primary Site Prediction
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Unknown Primary Cancer
Both
Unknown Primary Cancer
Trial Information
Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer: Role in Clinical Management and Primary Site Prediction
Inclusion Criteria:
- Patients with RT-PCR testing completed since commercialization of the RT-PCR assay in
2007.
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Outcome Measure:
To correlate the tissue of origin predicted by the RT-PCR assay with clinical and pathologic features of patients with carcinoma of unknown primary site.
Outcome Time Frame:
6 months
Safety Issue:
No
Principal Investigator
Frank A Greco, M.D.
Investigator Role:
Study Chair
Investigator Affiliation:
Sarah Cannon Research Institute
Authority:
United States: Institutional Review Board
Study ID:
SCRI OUTCOMES 08
NCT ID:
NCT00876408
Start Date:
May 2009
Completion Date:
August 2013
Related Keywords:
- Unknown Primary Cancer
- RT-PCR molecular profiling assay
- Molecular Profiling-Real Time Polymerase Chain Reaction
- Unknown Primary
- UPC
- CUP
- Neoplasms, Unknown Primary
Name | Location |
|---|---|
| Tennessee Oncology, PLLC | Clarksville, Tennessee 37043 |
